News Media

Dr. Pramad Dhembare Awarded with IAE International Pharma Awards 2021 For The Category of "Entrepreneur of the year".

I am honoured to receive IAE International Pharma Awards 2021 for the category of Entrepreneur of the year. I would like to dedicate this award to all our teams of nearly 300 dedicated and energetic people at Fidelity group companies.

Fidelity Diagnostics Provides 20,000 HRCT Scans In 2 Months

The healthcare system of India was in turmoil after COVID - 19 gripped the entire nation.With a lack of equipment and a constant rise in the mortality.we decided to take part and do everything in our capacity and medical capabilities to counter the crises.

We Are Early Adopters of Technological Breakthroughs

Dr. Pramod Dhembare : Because of our enduring reliance, patronage of our doctors and the faith of our patients, Fidelity Diagnostics has now become trusted and reliable in this field of Medical imaging in the western part of India.

PharmEasy -Thyrocare deal going to be game changer for B2C diagnostics space

Fidelity Diagnostics is continuously augmenting its growth efforts by looking into new markets,new verticals, new services,and value-added plays, like getting centres accredited and leveraging tech capability to deliver better customer experience.

AI is the next big tech revolution to make diagnosis efficient and fast

Dr. Dhembare stated that AI is the next big tech revolution that creates algorithms, making the diagnosis for a radiologist precise., efficient and fast.

AI: Driving the future of diagnostics

The benefits of AI extend to imaging and radiology by removing cognitive bias and detecting signs that the human eye might miss.AI-based systems can thus offer a second opinion to physicians to prevent misdiagnosis or overdiagnosis.